KeyBank National Association’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.72M Sell
18,466
-2,617
-12% -$1.47M 0.03% 251
2026
Q1
$11.8M Sell
21,083
-134
-0.6% -$85.9K 0.04% 221
2025
Q4
$14.4M Buy
21,217
+407
+2% +$277K 0.05% 204
2025
Q3
$13.3M Buy
20,810
+16,825
+422% +$10.2M 0.05% 207
2025
Q2
$2.14M Sell
3,985
-76
-2% -$36.3K 0.01% 431
2025
Q1
$1.71M Buy
4,061
+294
+8% +$128K 0.01% 448
2024
Q4
$1.56M Buy
3,767
+2
+0.1% +$877 0.01% 470
2024
Q3
$1.9M Buy
3,765
+111
+3% +$53.9K 0.01% 428
2024
Q2
$1.78M Buy
3,654
+55
+2% +$27.6K 0.01% 430
2024
Q1
$1.94M Sell
3,599
-120
-3% -$65.6K 0.01% 407
2023
Q4
$2.06M Buy
3,719
+118
+3% +$55.4K 0.01% 394
2023
Q3
$1.57M Buy
3,601
+316
+10% +$158K 0.01% 394
2023
Q2
$1.65M Buy
3,285
+25
+0.8% +$12K 0.01% 401
2023
Q1
$1.63M Sell
3,260
-39
-1% -$18.7K 0.01% 403
2022
Q4
$1.35M Sell
3,299
-138
-4% -$53.6K 0.01% 412
2022
Q3
$1.12M Buy
3,437
+150
+5% +$55.1K 0.01% 428
2022
Q2
$1.15M Sell
3,287
-827
-20% -$337K 0.01% 437
2022
Q1
$2.25M Sell
4,114
-357
-8% -$188K 0.01% 361
2021
Q4
$2.94M Sell
4,471
-515
-10% -$323K 0.01% 333
2021
Q3
$3.1M Buy
4,986
+1,197
+32% +$804K 0.01% 319
2021
Q2
$2.39M Buy
3,789
+198
+6% +$109K 0.01% 351
2021
Q1
$1.76M Sell
3,591
-513
-13% -$257K 0.01% 388
2020
Q4
$2.05M Buy
4,104
+538
+15% +$241K 0.01% 358
2020
Q3
$1.4M Sell
3,566
-201
-5% -$74.3K 0.01% 396
2020
Q2
$1.24M Sell
3,767
-97
-3% -$28.1K 0.01% 410
2020
Q1
$936K Buy
3,864
+512
+15% +$134K 0.01% 444
2019
Q4
$875K Sell
3,352
-1,375
-29% -$362K ﹤0.01% 568
2019
Q3
$1.28M Buy
4,727
+1,335
+39% +$371K 0.01% 435
2019
Q2
$934K Sell
3,392
-43
-1% -$10.6K 0.01% 557
2019
Q1
$768K Buy
3,435
+403
+13% +$83.2K ﹤0.01% 605
2018
Q4
$564K Buy
3,032
+251
+9% +$51.5K ﹤0.01% 634
2018
Q3
$694K Buy
2,781
+293
+12% +$71.1K ﹤0.01% 678
2018
Q2
$542K Sell
2,488
-54
-2% -$11.1K ﹤0.01% 718
2018
Q1
$487K Sell
2,542
-523
-17% -$96.5K ﹤0.01% 749
2017
Q4
$479K Sell
3,065
-442
-13% -$69.6K ﹤0.01% 761
2017
Q3
$545K Sell
3,507
-133
-4% -$21K ﹤0.01% 750
2017
Q2
$588K Sell
3,640
-21,204
-85% -$3.44M ﹤0.01% 760
2017
Q1
$3.84M Sell
24,844
-917
-4% -$126K 0.02% 277
2016
Q4
$3.02M Hold
25,761
0.02% 304
2016
Q3
$2.9M Sell
25,761
-6,283
-20% -$662K 0.02% 303
2016
Q2
$2.98M Sell
32,044
-6,608
-17% -$567K 0.02% 284
2016
Q1
$3.03M Sell
38,652
-2,265
-6% -$163K 0.02% 282
2015
Q4
$2.98M Sell
40,917
-1,121
-3% -$80K 0.02% 290
2015
Q3
$3.12M Sell
42,038
-2,465
-6% -$177K 0.02% 291
2015
Q2
$2.85M Sell
44,503
-423
-0.9% -$29.3K 0.02% 319
2015
Q1
$3.47M Buy
44,926
+1,742
+4% +$136K 0.02% 310
2014
Q4
$3.2M Sell
43,184
-3,322
-7% -$233K 0.02% 309
2014
Q3
$2.74M Buy
46,506
+504
+1% +$31.9K 0.02% 333
2014
Q2
$3.07M Sell
46,002
-3,116
-6% -$198K 0.02% 324
2014
Q1
$2.98M Sell
49,118
-11,506
-19% -$685K 0.02% 324
2013
Q4
$3.22M Buy
60,624
+44,846
+284% +$2.36M 0.02% 310
2013
Q3
$786K Sell
15,778
-20,464
-56% -$984K 0.01% 717
2013
Q2
$1.63M Buy
+36,242
New +$1.58M 0.01% 676

Other funds holding IDXX

KeyBank National Association's IDXX Position: Q2 2026 in Review

KeyBank National Association reduced its Idexx Laboratories (IDXX) stake by 12% in Q2 2026, selling an estimated $1.47M and leaving 18,466 shares worth $9.72M. The position accounts for 0.03% of the portfolio, ranked #251.

KeyBank National Association first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.4M in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • KeyBank National Association held 18,466 shares of Idexx Laboratories worth $9.72M as of Q2 2026.
  • KeyBank National Association sold 2,617 Idexx Laboratories shares in Q2 2026, an estimated $1.47M.
  • Idexx Laboratories made up 0.03% of KeyBank National Association's portfolio in Q2 2026, its #251 holding.
  • KeyBank National Association first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • KeyBank National Association's Idexx Laboratories position peaked at $14.4M in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.